Archives of Toxicology

, Volume 87, Issue 2, pp 249–258 | Cite as

Impact of lead and mercuric ions on the interleukin-2-dependent proliferation and survival of T cells

  • Andrea Jorissen
  • Laura M. Plum
  • Lothar Rink
  • Hajo Haase
Inorganic Compounds


Mercury and lead are widespread in the environment, causing chronic exposure of a large population to low concentrations of these metals. While several studies demonstrated that low levels of both metals affect the immune system, little is known about underlying molecular mechanisms. The objective of this study was to investigate the impact of mercuric (Hg2+) and lead (Pb2+) ions on T cells. Up to 100 μM Pb(NO3)2 had no effect on cellular viability and proliferation. In contrast, HgCl2 caused a concentration-dependent decline of viable leukocytes and especially of activated T cells. Additionally, Hg2+ induced reactive oxygen species (ROS) generation accompanied by the loss of mitochondrial transmembrane potential, measured by Dihydrorhodamine and Rhodamine-123, respectively. The antioxidant N-acetylcysteine partially reversed the toxic effects of Hg2+, pointing to an involvement of ROS. The major cytokine controlling T-cell survival and proliferation is interleukin (IL)-2. Hg2+ had no effect on the secretion of IL-2, but on IL-2 mediated signal transduction pathways, reducing phosphorylation of the downstream kinases ERK1/2 and AKT. Moreover, Hg2+ led to an arrest of the cells in the S phase of the cell cycle. Taken together, these data fit a model in which Hg2+ disrupts mitochondria, and the resulting release of ROS inhibits IL-2-dependent signal transduction, reducing proliferation and survival of T cells.


Mercury Lead T cells IL-2 Proliferation ROS 


  1. Andersen A, Julshamn K, Ringdal O, Mørkøre J (1987) Trace elements intake in the Faroe Islands. II. Intake of mercury and other elements by consumption of pilot whales (Globicephalus meleanus). Sci Total Environ 65:63–68PubMedCrossRefGoogle Scholar
  2. Aten J, Prigent P, Poncet P, Blanpied C, Claessen N, Druet P, Hirsch F (1995) Mercuric chloride-induced programmed cell death of a murine T cell hybridoma. Cell Immunol 161:98–106PubMedCrossRefGoogle Scholar
  3. Benczik M, Gaffen SL (2004) The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol Investig 33:109–142CrossRefGoogle Scholar
  4. Bernier J, Brousseau P, Krzystyniak K (1995) Immunotoxicity of heavy metals in relation to great lakes. Environ Health Perspect 103:23–34PubMedGoogle Scholar
  5. Björkman L, Lundekvam BF, Lægreid T, Bertelsen BI, Morild I, Lilleng P, Lind B, Palm B, Vahter M (2007) Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environ Health 6:1–14CrossRefGoogle Scholar
  6. Clarkson TW, Vyas JB, Ballatori N (2007) Mechanisms of mercury disposition in the body. Am J Ind Med 50:757–764PubMedCrossRefGoogle Scholar
  7. Colombo M, Hamelin C, Kouassi E, Fournier M, Bernier J (2004) Differential effects of mercury, lead, and cadmium on IL-2 production by Jurkat T cells. Clin Immunol 111:311–322PubMedCrossRefGoogle Scholar
  8. Crabtree GR (1989) Contingent genetic regulatory events in T lymphocyte activation. Science 243:355–361PubMedCrossRefGoogle Scholar
  9. Dìaz Rizo O, Echeverrìa Castillo F, Arado López JO, Hernández Merlo M (2011) Assessment of heavy metal pollution in urban soils of Havana City. Cuba Bull Environ Contam Toxicol 87:414–419CrossRefGoogle Scholar
  10. Dietert RR, Piepenbrink MS (2006) Lead and immune function. Crit Rev Toxicol 36:359–385PubMedCrossRefGoogle Scholar
  11. Fracasso ME, Perbellini L, Soldà S, Talamini G, Franceschetti P (2002) Lead induced DNA strand breaks in lymphocytes of exposed workers: role of reactive oxygen species and protein kinase C. Mutat Res 515:159–169PubMedCrossRefGoogle Scholar
  12. Gaffen SL (2001) Signaling domains of the interleukin-2 receptor. Cytokine 14:63–77PubMedCrossRefGoogle Scholar
  13. Gaffen SL, Liu KD (2004) Overview of interleukin-2 function, production and clinical applications. Cytokine 28:109–123PubMedCrossRefGoogle Scholar
  14. Gainer JH (1974) Lead aggravates viral disease and represses the antiviral activity of Interferon inducers. Environ Health Perspect 7:113–119PubMedCrossRefGoogle Scholar
  15. García Gómez M, Klink JDC, Boffetta P, Espanol S, Sällsten G, Gómez Quintana J (2007) Exposure to mercury in the mine of Almadén. Occup Environ Med 64:389–395PubMedCrossRefGoogle Scholar
  16. Haase H, Ober-Blobaum JL, Engelhardt G, Hebel S, Heit A, Heine H, Rink L (2008) Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J Immunol 181:6491–6502PubMedGoogle Scholar
  17. Haase H, Engelhardt G, Hebel S, Rink L (2011) Mercuric ions inhibit mitogen-activated protein kinase dephosphorylation by inducing reactive oxygen species. Toxicol Appl Pharmacol 250:78–86PubMedCrossRefGoogle Scholar
  18. Heo Y, Parson PJ, Lawrence DA (1996) Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol 138:149–157PubMedCrossRefGoogle Scholar
  19. Juntilla MR, Li SP, Westermarck J (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 22:954–965CrossRefGoogle Scholar
  20. Kaltenberg J, Plum LM, Ober-Blöbaum JL, Hönscheid A, Rink L, Haase H (2010) Zinc signals promote IL-2 dependent proliferation of T cells. Eur J Immunol 40:1496–1503PubMedCrossRefGoogle Scholar
  21. Karagas MR, Choi AL, Oken E, Horvat M, Schoeny R, Kamai E, Cowell W, Grandjean P, Korrick S (2012) Evidence on the human health effects of low level methylmercury exposure. Environ Health Perspect 120(6):799–806Google Scholar
  22. Kim SH, Sharma RP (2005) Mercury alters endotoxin-induced inflammatory cytokine expression in liver: differential roles of p38 and extracellular signal-regulated mitogen-activated protein kinases. Immunopharmacol Immunotoxicol 27:123–135PubMedGoogle Scholar
  23. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1–24PubMedCrossRefGoogle Scholar
  24. Lawrence DA (1981) In vivo and in vitro effects of lead on humoral and cell-mediated immunity. Infect Immun 31:136–143PubMedGoogle Scholar
  25. Malek TR (2008) The biology of interleukin-2. Annu Rev Immunol 26:453–479PubMedCrossRefGoogle Scholar
  26. Martinsson K, Carlsson L, Kleinau S, Hultman P (2008) The effect of activating and inhibiting Fc-receptors on murine mercury-induced autoimmunity. J Autoimmun 31:22–29PubMedCrossRefGoogle Scholar
  27. Mattingly RR, Felczak A, Chen CC, McCabe MJ Jr, Rosenspire AJ (2001) Low concentrations of inorganic mercury inhibit Ras activation during T cell receptor-mediated signal transduction. Toxicol Appl Pharmacol 176:162–168PubMedCrossRefGoogle Scholar
  28. McCabe MJ Jr, Lawrence DA (1991) Lead, a major environmental pollutant, is immunomodulatory by its differential effects on CD4+ T cell subsets. Toxicol Appl Pharmacol 111:13–23PubMedCrossRefGoogle Scholar
  29. Nakatsuru S, Oohashi J, Nozaki H, Nakada S, Imura N (1985) Effect of mercurials on lymphocyte functions in vitro. Toxicology 36:297–305PubMedCrossRefGoogle Scholar
  30. Nielson JB, Hultman P (2002) Mercury-induced autoimmunity in mice. Environ Health Perspect 110:877–881CrossRefGoogle Scholar
  31. Queiroz MLS, Perlingeiro RCR, Bincoletto C, Almeida M, Cardoso MP, Dantas DCM (1994) Immunoglobulin levels and cellular immune function in lead exposed workers. Immunopharmacol Immunotoxicol 16:115–128PubMedCrossRefGoogle Scholar
  32. Rosenspire AJ, Bodepudi S, Mathews M, McCabe MJ Jr (1998) Low levels of ionic mercury modulate protein tyrosine phosphorylation in lymphocytes. Int J Immunopharmacol 20:697–707PubMedCrossRefGoogle Scholar
  33. Rossi A, Manzo L, Orrenius S, Vahter M, Nicotera P (1991) Modifications of cell signalling in the cytotoxicity of metals. Pharmacol Toxicol 68:424–429PubMedCrossRefGoogle Scholar
  34. Shen X, Lee K, König R (2001) Effects of heavy metal ions on resting and antigen-activated CD4+ T cells. Toxicology 169:67–80PubMedCrossRefGoogle Scholar
  35. Shenker BJ, Berthold P, Decker S, Mayro J, Rooney C, Vitale L, Shapiro IM (1992) Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes II. Alterations in cell viability. Immunopharmacol Immunotoxicol 14:555–577PubMedCrossRefGoogle Scholar
  36. Shenker BJ, Guo TL, O I, Shapiro IM (1999) Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol 157:23–35Google Scholar
  37. Steelman LS, Abrams SL, Whelan J, Bertrand FE, Ludwig DE, Bäsecke J, Libra M, Stivala F, Milella M, Tafuri A, Lunghi P, Bonati A, Martelli AM, McCubrey JA (2008) Contributions of the Raf/MEK/ERK, PI3 K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. Leukemia 22:686–707PubMedCrossRefGoogle Scholar
  38. van der Meide PH, de Labie MCDC, Botman CAD, van Bennekom WP, Olsson T, Aten J, Weening JJ (1993) Mercuric chloride down-regulates T cell interferon-γ production in brown norway but not in lewis rats; role of glutathione. Eur J Immunol 23:675–681PubMedCrossRefGoogle Scholar
  39. Vas J, Monestier M (2008) Immunology of mercury. Ann NY Acad Sci 1143:240–267PubMedCrossRefGoogle Scholar
  40. WHO, World Health Organization (1991) Inorganic mercury. Environ Health Criteria 118Google Scholar
  41. WHO, World Health Organization (1995) Inorganic lead. Environ Health Criteria 165Google Scholar
  42. Wild LG, Ortega HG, Lopez M, Salvaggio JE (1997) Immune system alteration in rat after indirect exposure to methyl mercury chloride or methyl mercury sulfide. Environ Res 74:34–42PubMedCrossRefGoogle Scholar
  43. Worth RG, Esper RM, Warra NS, Kindzelskii AL, Rosenspire AJ, Todd RF III, Petty HR (2001) Mercury inhibition of neutrophil activity: evidence of aberrant cellular signalling and incoherent cellular metabolism. Scand J Immunol 53:49–55PubMedCrossRefGoogle Scholar
  44. Yang K, Hitomi M, Stacey DW (2006) Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Division 1:1–8CrossRefGoogle Scholar
  45. Ziemba SE, Mattingly RR, McCabe MJ Jr, Rosenspire AJ (2005) Inorganic mercury inhibits the activation of LAT in T-cell receptor-mediated signal transduction. Toxicol Sci 89:145–153PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Andrea Jorissen
    • 1
  • Laura M. Plum
    • 1
  • Lothar Rink
    • 1
  • Hajo Haase
    • 1
  1. 1.Institute of Immunology, Medical FacultyRWTH Aachen UniversityAachenGermany

Personalised recommendations